Add to cart
For research use only.
Product Summary
Sample Volume | 100 μL |
Total Assay Time | 1 h 30 min |
Reacitivity | Human |
Specificity | This kit recognizes Human SARS-CoV-2 IgG in samples.No significant cross-reactivity or interference between Human SARS-CoV-2 IgG and analogues was observed |
Recovery | 80%-120% |
Sample Type | serum, plasma |
Detection Method | Colorimetric method, ELISA, Indirect |
Assay Type | Indirect-ELISA |
Size | 96T |
Storage | 2-8℃ |
Expiration Date | 12 months |
Test Principle
This ELISA kit uses Indirect-ELISA as the method to qualitatively detect the SARS-CoV-2 Nucleocapsid protein IgG in the sample. The micro ELISA plate provided in this kit is pre-coated with purified SARS-CoV-2 Nucleocapsid protein (E-ELC-001) antigen, after adding samples to wells, the SARS-CoV-2 Nucleocapsid protein IgG in the samples will combine with the pre-coated SARS-CoV-2 Nucleocapsid protein antigen. After washing completely, add Horseradish Peroxidase (HRP) conjugated mouse anti human IgG to develop the antigen-antibody-HRP conjugated secondary antibody complex. Free components are washed away, then the substrate solution is added to each well. Only those wells that contain SARS-CoV-2 Nucleocapsid protein IgG and HRP conjugated anti-human IgG will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 ± 2 nm. Compared with the CUT OFF value to judge whether SARS-CoV-2 Nucleocapsid protein IgG exists in the tested samples or not.
Background
SARS-CoV-2 N protein IgG antibody is an IgG type of antibody produced against the N protein (nucleocapsid protein) of the novel coronavirus (SARS-CoV-2). N protein is an important structural protein of SARS-CoV-2 virus, which plays a key role in the process of virus replication and assembly
Research Area | SARS-CoV-2, COVID 19 |
Other Clones
1 Results
Other Formats
1 Results